U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07682662) titled 'Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis' on June 26.
Brief Summary: The goal of this study is to learn if Ketamine works more efficiently, as compared to Opioids, for Sickle Cell Pain The main questions it aims to answer are:
Does Ketamine lower the number of times participants need to be admitted for continued pain control during a Sickle Cell Pain Crisis.
Does Ketamine decrease the amount of time it takes to reach adequate pain control/pain score improvement, as compared to Opioids.
Patients could have too low or too high blood pressure or sleepiness. Researchers will compare Ketamine to Opioids (Morphine or D...